To validate our findings from the proteomics analysis, we selected several identified transcription factors relevant to the B cells or CLL based on the literature and tested their impact on the reporter gene expression under the minimal CD22 promoter in the 293T cells by cotransfection. The gene discussed is CD22; the disease is B-cell chronic lymphocytic leukemia.